Baupost Group - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 135 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baupost Group ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,465
-8.1%
9,773,6160.0%0.28%
-1.1%
Q2 2023$15,736
-40.5%
9,773,616
+7.1%
0.28%
-38.1%
Q1 2023$26,458
-0.7%
9,123,616
+12.3%
0.45%
+3.9%
Q4 2022$26,645
-99.9%
8,123,6160.0%0.44%
-17.9%
Q3 2022$30,707,000
-51.5%
8,123,6160.0%0.53%
-43.3%
Q2 2022$63,283,000
-16.1%
8,123,6160.0%0.94%
+15.3%
Q1 2022$75,468,000
-43.5%
8,123,616
-4.2%
0.81%
-38.5%
Q4 2021$133,605,000
-12.0%
8,477,4880.0%1.32%
-5.4%
Q3 2021$151,747,000
+15.1%
8,477,4880.0%1.39%
+30.3%
Q2 2021$131,825,000
+8.3%
8,477,4880.0%1.07%
+10.4%
Q1 2021$121,737,000
-31.9%
8,477,488
-6.9%
0.97%
-41.3%
Q4 2020$178,809,000
+39.1%
9,108,988
-8.2%
1.65%
+18.7%
Q3 2020$128,590,000
-11.0%
9,922,0300.0%1.39%
-23.0%
Q2 2020$144,564,000
+104.4%
9,922,030
+19.4%
1.80%
+72.9%
Q1 2020$70,709,000
-48.3%
8,308,9000.0%1.04%
-30.9%
Q4 2019$136,848,000
+16.6%
8,308,9000.0%1.51%
+13.7%
Q3 2019$117,322,000
-16.7%
8,308,900
+18.7%
1.33%
+4.3%
Q2 2019$140,770,000
-44.5%
7,000,000
+9.7%
1.27%
-40.2%
Q1 2019$253,626,000
+16.7%
6,380,519
+2.0%
2.13%
+13.0%
Q4 2018$217,286,000
-16.0%
6,254,6320.0%1.89%
-4.8%
Q3 2018$258,629,000
+12.5%
6,254,6320.0%1.98%
-1.4%
Q2 2018$229,858,000
-5.8%
6,254,6320.0%2.01%
-14.5%
Q1 2018$243,931,000
+151.5%
6,254,632
+16.7%
2.35%
+145.3%
Q4 2017$97,009,000
+9.4%
5,359,6320.0%0.96%
-13.3%
Q3 2017$88,702,000
+18.2%
5,359,6320.0%1.11%
+29.1%
Q2 2017$75,035,000
-31.9%
5,359,6320.0%0.86%
-33.9%
Q1 2017$110,140,000
+44.7%
5,359,6320.0%1.30%
+30.7%
Q4 2016$76,107,000
-33.6%
5,359,6320.0%0.99%
-39.1%
Q3 2016$114,643,000
-5.0%
5,359,6320.0%1.63%
-0.5%
Q2 2016$120,645,000
+18.3%
5,359,6320.0%1.64%
+11.2%
Q1 2016$101,994,000
-27.9%
5,359,6320.0%1.47%
-42.6%
Q4 2015$141,548,000
-16.0%
5,359,6320.0%2.57%
-8.6%
Q3 2015$168,507,000
-33.6%
5,359,632
+11.4%
2.81%
-33.6%
Q2 2015$253,756,000
+31.6%
4,809,632
+1.0%
4.23%
+30.6%
Q1 2015$192,802,000
+226.0%
4,763,265
+90.8%
3.24%
+178.8%
Q4 2014$59,137,0002,495,9131.16%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders